Mythili Kameswaran

ScholarGPS® ID: 71835031481459

Affiliation

Bhabha Atomic Research Centre, Mumbai, India

Affiliation History

Field

Medicine

Discipline

Nuclear Medicine

Top Specialties

Cancer | Radiation | Rituximab | Tuberculosis

Metrics Summary

Publication Count

Predicted Citations

384

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Critical APJ receptor residues in extracellular domains that influence effector selectivity (journal article) Ashokan, Anisha \| Harisankar, Harikumar Sheela \| Kameswaran, Mythili \| Aradhyam, Gopala Krishna The FEBS Journal, volume 288, issue 22, pages 6543-6562 (2021). 10.1111/febs.16048 Cited by (4) \| Cite \| Source
Analysis of absorbed dose in radioimmunotherapy with 177Lu-trastuzumab using two different imaging scenarios: a pilot study (journal article) Nautiyal, Amit \| Jha, Ashish K. \| Mithun, Sneha \| Shetye, Bhakti \| Kameswaran, Mythili \| Shah, Sneha \| Rangarajan, Venkatesh \| Gupta, Sudeep Nuclear Medicine Communications, volume 42, issue 12, pages 1382-1395 (2021). 10.1097/MNM.0000000000001472 Cited by (6) \| Cite \| Source
Induction of different cellular arrest and molecular responses in low EGFR expressing A549 and high EGFR expressing A431 tumor cells treated with various doses of177 Lu-Nimotuzumab (journal article) Suman, ShishuKant \| Priya, Rashmi \| Kameswaran, Mythili International Journal of Radiation Biology, volume 96, issue 9, pages 1144-1156 (2020). 10.1080/09553002.2020.1793012 Cited by (5) \| Cite \| Source
Comparative In Vitro Cytotoxicity Studies of177 Lu-CHX-A″-DTPA-Trastuzumab and177 Lu-CHX-A″-DTPA-F(ab′)2 -Trastuzumab in HER2-Positive Cancer Cell Lines (journal article) Sharma, Rohit \| Kameswaran, Mythili \| Dash, Ashutosh Cancer Biotherapy and Radiopharmaceuticals, volume 35, issue 3, pages 177-189 (2020). 10.1089/cbr.2019.2882 Cited by (6) \| Cite \| Source
Dose-dependent cell cycle arrest and apoptosis in HER2 breast cancer cells by177 Lu-CHX-A“-DTPA-Trastuzumab (journal article) Sharma, Rohit \| Kameswaran, Mythili \| Pandey, Usha \| Dash, Ashutosh Journal of Cancer Research and Therapeutics, volume 16, issue 6, pages 1426- (2020). 10.4103/jcrt.JCRT_20_19 Cite \| Source
Synthesis and preliminary evaluation of 99mTc-Hynic-fragments [F(ab')2 and F(ab')] of Rituximab as radioimmunoscintigraphic agents for patients with Non-Hodgkin's lymphoma (journal article) Suman, Shishu Kant \| Kameswaran, Mythili \| Mallia, Madhava \| Mittal, Sweety \| Dash, Ashutosh Applied Radiation and Isotopes, volume 153 (2019). 10.1016/j.apradiso.2019.108808 Cited by (6) \| Cite \| Source
Preparation and preliminary bioevaluation studies of68 Ga‐NOTA‐rituximab fragments as radioimmunoscintigraphic agents for non‐Hodgkin lymphoma (journal article) Suman, Shishu Kant \| Kameswaran, Mythili \| Pandey, Usha \| Sarma, Haladhar Dev \| Dash, Ashutosh Journal of Labelled Compounds and Radiopharmaceuticals, volume 62, issue 12, pages 850-859 (2019). 10.1002/jlcr.3803 Cited by (10) \| Cite \| Source
Synthesis, radiolabeling, and evaluation of gastrin releasing peptide receptor antagonist68 Ga‐HBED‐CC‐RM26 (journal article) Satpati, Drishty \| Vats, Kusum \| Sharma, Rohit \| Kameswaran, Mythili \| Sarma, Haladhar Dev \| Dash, Ashutosh Journal of Labelled Compounds and Radiopharmaceuticals, volume 62, issue 12, pages 843-849 (2019). 10.1002/jlcr.3795 Cited by (4) \| Cite \| Source
Design, synthesis, and comparative evaluation of99m Tc(CO)3 ‐labeled N‐terminal and C‐terminal modified asparagine–glycine–arginine peptide constructs (journal article) Vats, Kusum \| Sharma, Rohit \| Kameswaran, Mythili \| Sarma, Haladhar Dev \| Satpati, Drishty \| Dash, Ashutosh Journal of Peptide Science, volume 25, issue 7 (2019). 10.1002/psc.3192 Cited by (5) \| Cite \| Source
Preparation of 177Lu-Trastuzumab injection for treatment of breast cancer (journal article) Kameswaran, Mythili \| Pandey, Usha \| Gamre, Naresh \| Sarma, Haladhar Dev \| Dash, Ashutosh Applied Radiation and Isotopes, volume 148 (2019). 10.1016/j.apradiso.2019.04.002 Cited by (12) \| Cite \| Source
Preparation of177 Lu‐labeled Nimotuzumab for radioimmunotherapy of EGFR‐positive cancers: Comparison of DOTA and CHX‐A″‐DTPA as bifunctional chelators (journal article) Pandey, Usha \| Kameswaran, Mythili \| Gamre, Naresh \| Dash, Ashutosh Journal of Labelled Compounds and Radiopharmaceuticals, volume 62, issue 4, pages 158-165 (2019). 10.1002/jlcr.3707 Cited by (8) \| Cite \| Source
Molecular determinants on extracellular loop domains that dictate interaction between β‐arrestin and human APJ receptor (journal article) Ashokan, Anisha \| Kameswaran, Mythili \| Aradhyam, Gopala Krishna FEBS Letters, volume 593, issue 6, pages 634-643 (2019). 10.1002/1873-3468.13344 Cited by (4) \| Cite \| Source
Single vial cold kits optimized for preparation of gastrin releasing peptide receptor (GRPR)-radioantagonist 68Ga-RM2 using three different 68Ge/68Ga generators (journal article) Vats, Kusum \| Sharma, Rohit \| Kameswaran, Mythili \| Satpati, Drishty \| Dash, Ashutosh Journal of Pharmaceutical and Biomedical Analysis, volume 163 (2019). 10.1016/j.jpba.2018.09.045 Cited by (4) \| Cite \| Source
Ready-to-use 177Lu-Rituximab injection for Non-Hodgkin’s Lymphoma: Formulation and preliminary clinical study (journal article) Kameswaran, Mythili \| Pandey, Usha \| Gamre, Naresh \| Shinto, Ajit \| Subramanian, Suresh \| Sarma, Haladhar Dev \| Kamleshwaran, K. K. \| Dash, Ashutosh Journal of Radioanalytical and Nuclear Chemistry, volume 318, issue 2, pages 849-856 (2018). 10.1007/s10967-018-6042-7 Cited by (2) \| Cite \| Source
Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies (journal article) Shinto, Ajit \| Mallia, Madhava \| Kameswaran, Mythili \| Kamaleshwaran, K \| Joseph, Jephy \| Radhakrishnan, E \| Upadhyay, Indira \| Subramaniam, R \| Sairam, Madhu \| Banerjee, Sharmila \| Dash, Ashutosh World Journal of Nuclear Medicine, volume 17, issue 04, pages 228-235 (2018). 10.4103/wjnm.WJNM_68_17 Cited by (9) \| Cite \| Source
Rhenium-188 hydroxyethane 1,1-diphosphonic acid (HEDP) for bone pain palliation using BARC-HEDP kits versus Pars-HEDP kits: A comparison on preparation and performance aspects at hospital radiopharmacy (journal article) Kalarickal Ramakurup, RadhakrishnanEdathuruthy \| Chirayil, Viju \| Pandiyan, Arun \| Mallia, MadhavaBalakrishna \| Kameswaran, Mythili \| Shinto, Ajit \| Dash, Ashutosh Indian Journal of Nuclear Medicine, volume 33, issue 4, pages 302- (2018). 10.4103/ijnm.IJNM_39_18 Cited by (2) \| Cite \| Source
68 Ga labeled Erlotinib: A novel PET probe for imaging EGFR over-expressing tumors (journal article) Jain, Akanksha \| Kameswaran, Mythili \| Pandey, Usha \| Prabhash, Kumar \| Sarma, Haladhar Dev \| Dash, Ashutosh Bioorganic & Medicinal Chemistry Letters, volume 27, issue 19, pages 4552-4557 (2017). 10.1016/j.bmcl.2017.08.065 Cited by (15) \| Cite \| Source
In Vitro Evaluation of188 Re-HEDP: A Mechanistic View of Bone Pain Palliations (journal article) Sharma, Rohit \| Kumar, Chandan \| Mallia, Madhava B. \| Kameswaran, Mythili \| Sarma, Haladhar D. \| Banerjee, Sharmila \| Dash, Ashutosh Cancer Biotherapy and Radiopharmaceuticals, volume 32, issue 5, pages 184-191 (2017). 10.1089/cbr.2017.2200 Cited by (7) \| Cite \| Source
Preclinical evaluation of 131 I-Bevacizumab – A prospective agent for radioimmunotherapy in VEGF expressing cancers (journal article) Kameswaran, Mythili \| Sarma, Haladhar Dev \| Dash, Ashutosh Applied Radiation and Isotopes, volume 123 (2017). 10.1016/j.apradiso.2017.02.024 Cited by (5) \| Cite \| Source
Preparation and preclinical evaluation of131 I‐trastuzumab for breast cancer (journal article) Kameswaran, Mythili \| Gota, Vikram \| Ambade, Rajwardhan \| Gupta, Sudeep \| Dash, Ashutosh Journal of Labelled Compounds and Radiopharmaceuticals, volume 60, issue 1, pages 12-19 (2017). 10.1002/jlcr.3465 Cited by (15) \| Cite \| Source \| Open Access